Promentis Pharmaceuticals

Developing therapies for neuropsychiatric and neurodevelopmental disorders.

Investment Team

Sector

Life Sciences

Category

Therapeutics

Location

Milwaukee, Wisconsin

Initial Investment

2016
Developing therapies for neuropsychiatric and neurodevelopmental disorders.

Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company, is developing innovative therapies for neuropsychiatric disorders.